Navigation Links
Wound Management Technologies Reaches Agreement in Principle for Exclusive Distribution of CellerateRx(R) Products in Italy

FORT WORTH, Texas, Aug. 11 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC, has reached agreement in principle with Biocure S.r.l. of Milan, Italy for the exclusive distribution in Italy of Wound Care's patented collagen CellerateRx(R) products. The final contract is expected to be finalized by the end of September.

As part of the agreement, Biocure will assist Wound Care with obtaining a CE Mark for Cellerate.

Cathy Bradshaw, president of Wound Care Innovations, said, "This is an important first step in providing Cellerate to Europe and the broader global markets. Diabetes is a growing worldwide health problem. We are strongly focused in building a national and global distribution network so that those suffering from the effects of diabetes worldwide can have access to the important wound management capabilities of Cellerate. Clinicians are having amazing results with Cellerate, particularly with diabetic wounds, and studies continue to support this. We are looking forward to obtaining a CE Mark for Cellerate, which will facilitate the expansion of sales in Europe and elsewhere.

"Global projections for the diabetes epidemic show an increase from 189 million patients in 2003 to 324 million patients in 2025, an increase of 72%. This is significant as statistics show that every 30 seconds a lower limb is lost somewhere in the world as a consequence of diabetes. In fact, diabetic ulcers are estimated to occur in 15% of all patients with diabetes. The direct cost of an amputation is estimated to be between $30,000 - $60,000," Bradshaw said.

Giovanni Pinamonti, President of Biocure said, "We are pleased with the opportunity to be appointed as the exclusive distribution channel for Cellerate in Italy, where there is a large and growing market for the kind of wound care provided by Cellerate. These products have demonstrated excellent results in evidence-based studies for those suffering from diabetes. We expect Cellerate will be an important addition in our ability to provide valuable healthcare products to the Italian market."

Biocure S.r.l. has been known for years in the pharmaceutical market of OTC products. Recently, they have included Corporate managers with long standing success stories with prestigious multinational pharmaceutical companies. This has allowed the acquisition of strategic implementation of partnerships with international research groups, engaged in developing proprietary and innovative technologies. Biocure is based in Milan, Italy. For more information, please visit the website

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTCBB:WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the company. The company is positioned and seeks to be a leading provider of wound care products. For more information on the company please visit the company's website at

For product information contact Cathy Bradshaw at 954-315-9242. For shareholder relations, contact Lucy Singleton at 817-820-7080.

Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Smith & Nephew Highlights Advanced Wound Management Progress
2. Smith & Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA
3. Wounded Warrior Project (WWP) Pushes for Senate Bill to Assist Family Caregivers of the Most Severely Injured Veterans
4. Paper Highlights Antimicrobial Effectiveness of Medical-Grade Honey in Topical Wound Care
5. Cryo-Cell Announces Celle(SM) Research and Development Collaboration for Chronic Wound Healing Management
6. RecoverCare and MedaSTAT USA to Merge, Creating Leading Provider of Wound Care and Bariatric Treatment Solutions for Acute and Post-Acute Care Markets
7. Wound Management Technologies, Inc Announces Conference Plans and Presentations on Advanced Wound Care Product
8. Wounded Warrior Project (WWP) Seeks to Provide Mind, Body and Spirit Healing for Combat Stress
9. National Alliance of Wound Care Has Credentialed Over 7000 Wound Care Professionals
10. Wound Care Certification Program Gives Healthcare Sales Professionals Competitive Edge in Tough Economy
11. Wounded Warrior Project (WWP) Expands Board of Directors
Post Your Comments:
(Date:11/30/2015)... Rosa, Calif. (PRWEB) , ... November 30, 2015 ... ... Management and Analytics for the last 15 years, announced today that Michigan-based Family ... A provider of care for over 45 years, FHC was awarded the largest ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... new additions to its industry-leading suite of automated breast density assessment and ... America (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s ...
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today that they are ... empowers dentists to make complex business decisions by providing the tools and information they ... fee survey with 10 procedures customized by zip code. , The Sikka Software ...
(Date:11/30/2015)... ... 2015 , ... Scott Newman MD, FACS of New York’s ... surgeons in the New York City area to utilize the new, non-invasive SculpSure™ ... laser treatment for fat loss in the abdomen, flanks, and other areas that ...
(Date:11/30/2015)... ... 30, 2015 , ... Innovaacom, a leading provider of medical ... survey of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, ... quality online and face-to-face education for pharmacists who are fast becoming the new ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 ... global biopharmaceutical leader dedicated to delivering transformative ... underserved medical conditions, today announced the launch ... (Recombinant), PEGylated], an extended circulating half-life recombinant ... based on full-length ADVATE [Antihemophilic Factor (Recombinant)]. ...
(Date:11/30/2015)... 30, 2015 (HK$,000)For the Six Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 ... , 421,979 , 384,242 , ... 34,719 , (18.3) Medical Insurance Administration Service ... 16.1 Medical Devices and Accessories Sales , 89,645 ... Herbal Medicines Sales , 2,822 , 2,917 ...
(Date:11/30/2015)... India , November 30, 2015 ... market research report "Dental Lasers Market by Product (Soft Tissue, ... Periodontitis), End User (Hospitals, Clinics), and Geography - Global Forecast ... 224.7 Million by 2020, at a CAGR of 5.2% during ... Browse 140 market data Tables and 62 Figures spread through ...
Breaking Medicine Technology: